How Lab Testing and Biomarkers Shape a Personalized Cognitive Recovery Plan

Two people can experience similar memory problems for very different reasons.

One person may be struggling with insulin resistance and unstable blood sugar.

Another may have significant sleep disruption, inflammation, nutrient deficiencies, thyroid concerns, vascular risk factors, or several overlapping contributors.

Their symptoms may sound similar:

“I keep forgetting conversations.”

“I cannot concentrate the way I used to.”

“I lose words in the middle of a sentence.”

“I feel mentally foggy.”

“I need more reminders than before.”

But similar symptoms do not necessarily mean that the same plan will be appropriate for both people.

This is why Alzheimer’s biomarker testing and comprehensive cognitive decline lab work can play an important role in a personalized approach.

At Michigan Cognitive Recovery Center at Lakeshore Woods Senior Living in Fort Gratiot, every participant in the ReCODE+ For Facilities Program™ begins with a comprehensive assessment that includes cognitive testing and laboratory work covering more than 36 biomarkers connected with cognitive health.

The results are considered alongside the participant’s medical history, cognitive stage, symptoms, daily function, lifestyle, medications, and other relevant information.

The goal is not simply to collect laboratory numbers.

The goal is to understand which possible contributors may be most relevant to the individual and use those findings to guide a personalized ReCODE Report™ and daily cognitive recovery plan.

Testing does not guarantee that a cause will be found.

It also does not guarantee that addressing an abnormal result will improve cognition.

However, it can help families and qualified professionals move away from guesswork and toward a more informed, individualized strategy.

Key Takeaways

• People with similar memory symptoms may have different biological and lifestyle contributors.
• Laboratory testing may examine inflammation, blood sugar regulation, insulin resistance, nutrient status, thyroid function, hormones, vascular health, and other factors.
• Alzheimer’s-specific biomarkers, such as amyloid and phosphorylated tau, are different from broader metabolic and health biomarkers.
• No single blood test provides a complete explanation for cognitive decline.
• Laboratory results must be interpreted alongside cognitive testing, symptoms, medical history, medication use, and daily function.
• At MCRC, assessment findings help inform a personalized ReCODE Report™ within the 12-month residential program.
• Testing should lead to clear priorities, structured implementation, monitoring, and appropriate re-evaluation.
• Results vary, and no laboratory finding or personalized plan can guarantee cognitive improvement.

What Is a Biomarker?

A biomarker is a measurable sign that provides information about a biological process, health condition, or response to an intervention.

Biomarkers may be measured through:

• Blood
• Urine
• Saliva
• Cerebrospinal fluid
• Medical imaging
• Genetic testing
• Physical measurements
• Cognitive assessments

A laboratory value such as blood glucose is a biomarker.

Blood pressure can also function as a biomarker.

Levels of certain vitamins, hormones, inflammatory markers, lipids, or proteins may provide additional information about processes occurring in the body.

In cognitive health, biomarkers may help answer different types of questions.

Some biomarkers are used to investigate Alzheimer’s-related brain pathology.

Others provide information about broader health conditions that may contribute to memory problems, mental fog, fatigue, vascular damage, inflammation, or reduced brain resilience.

These categories should not be confused.

Two Different Meanings of Alzheimer’s Biomarker Testing

The phrase Alzheimer’s biomarker testing is often used broadly, but it can refer to two different types of testing.

Alzheimer’s disease pathology biomarkers

Certain biomarkers are specifically connected with biological changes associated with Alzheimer’s disease.

These may include:

• Amyloid-beta
• Phosphorylated tau
• Total tau
• Other indicators of neurodegeneration

Some may be evaluated through cerebrospinal fluid, PET imaging, or specialized blood testing.

These tests are generally used as part of a diagnostic workup under appropriate clinical guidance.

They should not be treated as standalone proof that a person does or does not have Alzheimer’s disease.

The Alzheimer’s Association explains that blood-based biomarker testing should be interpreted within a broader diagnostic process that includes clinical evaluation and other appropriate examinations. A positive result may require confirmation, depending on the test and clinical setting.

Broader cognitive-health biomarkers

A precision-medicine approach may also evaluate factors that are not themselves diagnostic markers for Alzheimer’s pathology but may affect cognitive function or overall brain health.

These may include markers related to:

• Inflammation
• Glucose regulation
• Insulin resistance
• Nutrient status
• Thyroid function
• Hormonal balance
• Lipid and vascular health
• Immune function
• Toxin exposure
• Infection
• Metabolic health

For example, a vitamin deficiency is not an Alzheimer’s disease biomarker.

However, it may contribute to memory problems or other neurological symptoms.

Similarly, insulin resistance does not prove that someone has Alzheimer’s disease, but metabolic dysfunction may be relevant to that person’s overall cognitive-health plan.

This distinction protects families from two common mistakes:

• Assuming that every abnormal laboratory result proves Alzheimer’s disease
• Assuming that normal basic blood work means there are no relevant contributors to investigate

Why Memory Symptoms Alone Do Not Reveal the Full Picture

Memory loss is a symptom.

It is not a complete explanation.

A person may experience cognitive changes because of one condition, several overlapping conditions, medication effects, lifestyle factors, neurological disease, or a combination of these.

Possible contributors may include:

• Poor sleep
• Sleep apnea
• Depression or anxiety
• Medication effects
• Thyroid problems
• Vitamin deficiencies
• Insulin resistance
• Blood sugar instability
• Vascular disease
• Chronic inflammation
• Hearing loss
• Alcohol use
• Recent illness
• Dehydration
• Infection
• Hormonal changes
• Neurological disease
• Alzheimer’s-related pathology

This is why a short cognitive screen alone may not answer every question.

Cognitive testing helps show how a person is performing in areas such as memory, attention, language, orientation, and executive function.

Laboratory testing may help identify biological factors that deserve further evaluation.

Medical history provides context.

Daily function shows how the changes are affecting real life.

A meaningful plan develops when these pieces are considered together.

Families can learn more about the assessment process in Memory Evaluation in Michigan: What Cognitive Testing Involves and When to Get One.

Why Personalized Testing Matters in Cognitive Recovery

A generic plan assumes that everyone with cognitive decline needs the same interventions.

A personalized plan asks a different question:

Which factors appear most relevant to this person?

Consider three hypothetical participants.

Participant A: Metabolic concerns

The first participant has elevated blood sugar, insulin resistance, poor sleep, limited exercise, and a diet high in processed carbohydrates.

Their plan may place greater emphasis on:

• Metabolic health
• Nutrition
• Meal timing
• Physical activity
• Sleep
• Weight and vascular risk management
• Clinical monitoring

Participant B: Nutrient and thyroid concerns

The second participant has different findings involving nutrient status, thyroid function, fatigue, and reduced physical activity.

Their priorities may include:

• Qualified medical evaluation
• Correction of confirmed deficiencies
• Thyroid management through an appropriate clinician
• Nutrition
• Gradual physical activity
• Monitoring of symptoms and laboratory values

Participant C: Inflammation and sleep disruption

The third participant has inflammatory concerns, poor-quality sleep, possible sleep-disordered breathing, chronic stress, and inconsistent daily routines.

Their plan may focus more heavily on:

• Sleep evaluation
• Stress reduction
• Medical investigation of inflammatory contributors
• Consistent routines
• Nutrition
• Movement
• Monitoring of cognitive and physical symptoms

These examples are not treatment recommendations.

They illustrate why the same cognitive symptoms can lead to different priorities after proper evaluation.

What Types of Biomarkers May Be Considered?

The exact laboratory work should be selected and interpreted by qualified professionals based on the participant’s history, symptoms, medications, risks, and clinical needs.

Not every person needs every available test.

The following categories explain what different areas of testing may help professionals understand.

1. Inflammation

Inflammation is part of the body’s normal immune response.

Short-term inflammation helps the body respond to injury or infection.

Persistent inflammation, however, may be associated with a variety of chronic health problems and may affect neurological and vascular health.

Depending on clinical judgment, inflammatory evaluation may help professionals consider questions such as:

• Is there evidence of ongoing systemic inflammation?
• Could infection, metabolic disease, autoimmune activity, oral health, excess body fat, poor sleep, or another condition be contributing?
• Does the pattern require further medical evaluation?
• Are changes over time moving in a healthier direction?

An elevated inflammatory marker does not automatically identify the cause.

It also does not prove that inflammation is causing the participant’s cognitive symptoms.

The result is a signal that must be interpreted in context.

Possible next steps may include further clinical investigation, medical treatment when appropriate, improved sleep, nutrition changes, movement, oral-health care, or management of metabolic conditions.

2. Blood Sugar and Insulin Resistance

The brain requires a consistent supply of energy.

Blood sugar instability and insulin resistance may affect energy regulation, vascular health, inflammation, and overall metabolic function.

Testing may help evaluate areas such as:

• Fasting glucose
• Long-term blood sugar control
• Fasting insulin
• Insulin resistance
• Metabolic syndrome
• Diabetes risk

A person can have metabolic concerns even before a formal diabetes diagnosis.

For this reason, looking only at one glucose reading may not provide the complete picture.

When metabolic dysfunction is identified, the personalized plan may give greater priority to:

• Nutrition
• Meal composition
• Meal timing
• Physical activity
• Sleep
• Weight management
• Medical care
• Ongoing monitoring

At MCRC, nutrition may include the KetoFLEX 12/3 approach as one part of the wider personalized ReCODE-based program.

The dietary strategy should still be adapted to the participant’s medical condition, nutritional needs, medications, weight, tolerance, and professional guidance.

3. Nutrient Status

The nervous system depends on adequate nutrients to support energy production, nerve function, blood formation, methylation, and other biological processes.

Deficiencies or imbalances may contribute to symptoms such as:

• Fatigue
• Mental fog
• Weakness
• Numbness or tingling
• Mood changes
• Poor concentration
• Memory concerns

Depending on the individual, testing may evaluate nutrients such as:

• Vitamin B12
• Folate
• Vitamin D
• Iron-related markers
• Magnesium
• Zinc
• Other nutrients considered clinically relevant

A low nutrient level should not automatically lead to high-dose supplementation.

The clinician must consider:

• Why the level is low
• Whether absorption is impaired
• Whether medications are contributing
• Whether diet is adequate
• Whether supplementation is appropriate
• Which dose is safe
• When the level should be rechecked

More is not always better.

Certain vitamins, minerals, and supplements can cause harm when taken unnecessarily or in excessive amounts.

Laboratory-guided supplementation is intended to replace guessing with appropriate clinical evaluation and monitoring.

4. Thyroid Function

Thyroid dysfunction can affect energy, mood, concentration, body temperature, heart rate, weight, sleep, and cognitive function.

Symptoms may overlap with those of depression, normal aging, medication effects, or neurological conditions.

Thyroid testing may help determine whether further evaluation is needed.

An abnormal result should be reviewed by a qualified clinician because interpretation can depend on:

• Symptoms
• Medical history
• Medication use
• Previous thyroid disease
• The specific markers tested
• The relationship between different thyroid values

Treating a confirmed thyroid condition may support overall health, but it should not be presented as a guaranteed way to reverse Alzheimer’s disease.

5. Hormonal Health

Hormones influence many systems connected with brain and body function.

Depending on age, sex, symptoms, health history, and clinical judgment, hormonal evaluation may be considered.

Relevant areas might include:

• Stress-related hormones
• Sex hormones
• Growth and repair signals
• Other endocrine factors

Hormonal values are complex.

A result cannot be interpreted safely without considering the person’s age, symptoms, medications, cancer history, cardiovascular risks, and broader medical condition.

Hormone treatment is not appropriate for every participant and should never be started solely because a value appears lower than a laboratory reference range.

Any hormonal intervention should be managed by a properly qualified healthcare professional.

6. Lipids and Vascular Health

The brain depends on healthy blood vessels to deliver oxygen and nutrients.

Vascular disease can contribute to cognitive impairment independently or alongside Alzheimer’s disease.

A laboratory and medical assessment may consider:

• Cholesterol patterns
• Triglycerides
• Blood pressure
• Blood sugar
• Smoking history
• Previous stroke or transient ischemic attack
• Cardiovascular disease
• Physical activity
• Other vascular risks

The purpose is not to label all cholesterol as harmful.

Lipids have important biological functions.

The goal is to understand the participant’s complete vascular and metabolic risk pattern and determine what requires medical or lifestyle attention.

A personalized plan may include appropriate medical management, exercise, nutrition, sleep support, blood pressure monitoring, and smoking cessation where relevant.

7. Homocysteine and Methylation-Related Factors

Homocysteine is an amino acid measured through blood testing.

Elevated levels may be associated with several factors, including nutrient deficiencies, kidney function, genetics, medication use, and other health conditions.

The value must be interpreted alongside the participant’s broader health information.

When an elevated result is identified, the next step is not simply to take random supplements.

The clinical team may need to evaluate:

• Vitamin B12
• Folate
• Vitamin B6
• Kidney health
• Medication use
• Diet
• Other contributing factors

The plan should address the likely reason for the abnormality rather than treating the laboratory number in isolation.

8. Immune Function and Infection

Certain infections or immune-related conditions can produce neurological or cognitive symptoms.

Testing may be considered when the person’s history, symptoms, exposure risk, physical findings, or other laboratory results provide a reason to investigate.

Broad testing without a clinical reason can produce confusing results, false positives, unnecessary anxiety, or inappropriate treatment.

For this reason, infection and immune testing should be targeted and interpreted by qualified professionals.

A positive antibody result, for example, may show past exposure rather than an active infection.

The meaning depends on the specific test and clinical situation.

9. Toxin and Environmental Exposure

Environmental exposure may be considered when a participant’s history suggests a meaningful risk.

Possible concerns may include:

• Occupational exposure
• Water damage or mold
• Heavy metals
• Air pollution
• Chemical exposure
• Contaminated food or water
• Repeated exposure in a home or workplace

Testing should not begin with the assumption that every person has a hidden toxin problem.

It should be guided by history, symptoms, exposure patterns, and professional judgment.

A result suggesting exposure may require confirmation, source identification, medical evaluation, and a carefully supervised response.

The word “detoxification” is sometimes used too casually.

In a responsible clinical context, it should mean identifying a credible exposure, reducing or removing the source when possible, supporting the body safely, and following qualified medical guidance.

10. Genetics

Genetic information may help explain risk, but it does not determine a person’s future by itself.

For example, APOE variants can influence Alzheimer’s risk and lipid metabolism.

Having a higher-risk variant does not prove that the person currently has Alzheimer’s disease.

It also does not guarantee that they will develop it.

A person without that variant can still develop cognitive decline.

Genetic information should be interpreted carefully and, when appropriate, with genetic counseling or qualified clinical guidance.

It may influence how professionals think about:

• Risk
• Lipid metabolism
• Lifestyle priorities
• Family history
• Additional evaluation
• Long-term monitoring

Genetics are one part of the picture, not the entire plan.

What Standard Memory Care May Not Test

Traditional memory care communities provide essential services such as:

• Safety
• Supervision
• Medication assistance
• Meals
• Personal care
• Structured activities
• Support with daily living
• Behavioral observation

However, many communities are not structured as comprehensive cognitive recovery programs.

Their assessments may focus mainly on:

• Level of cognitive impairment
• Safety risk
• Functional ability
• Behavior
• Medication management
• Care needs

These assessments are important, but they may not include detailed investigation of metabolic, inflammatory, nutritional, hormonal, vascular, or other biological contributors.

Families can learn more about this distinction in What Most Memory Care Communities Don’t Test For.

Comprehensive testing does not make traditional memory care unimportant.

The two models may have different goals.

Traditional memory care often focuses on supporting a person safely as cognitive decline progresses.

A cognitive recovery program adds a structured effort to investigate possible contributors and develop a personalized intervention plan for appropriate early-stage candidates.

How Test Results Become a Personalized ReCODE Report™

Laboratory results should not remain as a stack of numbers in a patient portal.

They must be organized into meaningful priorities.

In the ReCODE model, information may include:

• Medical history
• Current symptoms
• Cognitive testing
• Laboratory findings
• Genetics when appropriate
• Medications
• Nutrition
• Sleep
• Exercise
• Stress
• Environmental exposure
• Daily function
• Family observations

The ReCODE Report™ helps turn this information into a more individualized framework.

Apollo Health describes ReCODE as a personalized approach that uses medical history, genetics, biomarkers, laboratory testing, and cognitive assessment to identify the participant’s contributing factors and guide a personalized plan.

At MCRC, that plan is implemented within a 12-month residential environment rather than being handed to the participant to manage alone at home.

The plan may include:

• KetoFLEX 12/3 nutrition
• Exercise and movement
• Sleep support
• Stress management
• Brain stimulation
• Supplementation based on identified needs
• Detoxification support when clinically relevant
• Structured routines
• Education
• Health coaching
• Clinical coordination
• Ongoing monitoring

Families can explore the complete residential approach in ReCODE Protocol in Residential Care: What Michigan Families Need to Know.

An Example of How Personalization Works

Imagine that two participants both receive similar scores on an initial cognitive assessment.

Their laboratory and medical findings are different.

Participant One

Findings may suggest:

• Insulin resistance
• Elevated triglycerides
• Poor sleep
• Limited exercise
• Inconsistent meal timing

The plan may prioritize:

• Metabolic nutrition
• Meal timing
• Gradual exercise
• Sleep evaluation
• Weight and vascular risk management
• Monitoring of glucose-related markers

Participant Two

Findings may suggest:

• Nutrient deficiencies
• Thyroid concerns
• Chronic inflammation
• Possible medication effects
• Reduced appetite

The plan may prioritize:

• Medical review
• Nutrient correction
• Thyroid evaluation
• Investigation of inflammatory contributors
• Medication review
• Nutritional support
• Monitoring of weight and energy

Both participants have cognitive concerns.

Their plans are not identical because their findings are not identical.

This is the central idea behind precision medicine for dementia and early cognitive decline:

The diagnosis may describe the condition, but the assessment helps shape the individual plan.

Why One Abnormal Result Is Not Enough

Laboratory results can be affected by many factors.

These may include:

• Recent illness
• Fasting status
• Dehydration
• Time of day
• Supplements
• Medications
• Temporary stress
• Laboratory variation
• Exercise
• Diet
• Underlying medical conditions

A single abnormal value may need to be repeated or interpreted alongside other results.

Similarly, a value within the laboratory reference range does not always mean that every health concern has been excluded.

Reference ranges describe patterns in a population.

They do not replace clinical judgment.

Qualified professionals must determine:

• Whether the result is meaningful
• Whether it fits the symptoms
• Whether it should be repeated
• Whether additional testing is needed
• Whether treatment is appropriate
• Whether the result changes the cognitive recovery plan

The purpose of testing is not to chase every number.

It is to identify meaningful patterns.

Why Trends Over Time Matter

Baseline testing provides a starting point.

Repeat testing may help show whether an identified problem is changing.

For example, monitoring may help professionals ask:

• Has blood sugar regulation improved?
• Has a confirmed nutrient deficiency been corrected?
• Are inflammatory markers moving in a healthier direction?
• Is thyroid management appropriate?
• Has vascular risk changed?
• Are interventions being tolerated safely?
• Do laboratory changes correspond with changes in energy, sleep, function, or cognition?

The timing of repeat testing depends on the marker, intervention, medical condition, and clinical judgment.

Not every value should be repeated at the same interval.

Some may change within weeks.

Others may require several months before re-evaluation becomes meaningful.

A better laboratory result is encouraging, but it should not automatically be interpreted as proof of cognitive recovery.

Likewise, cognitive improvement may not always occur at the same rate as changes in metabolic or nutritional markers.

Progress should be evaluated across several areas:

• Cognitive testing
• Laboratory trends
• Daily function
• Sleep
• Energy
• Mood
• Mobility
• Participation
• Family observations
• Overall health

Why Testing Without Implementation Is Not Enough

A detailed report has limited value if the participant cannot follow the recommendations.

This is one of the challenges families may face when attempting a complex plan at home.

A caregiver may be expected to:

• Coordinate laboratory appointments
• Track results
• Prepare specialized meals
• Organize supplements
• Encourage exercise
• Improve sleep routines
• Arrange cognitive activities
• Communicate with providers
• Monitor symptoms
• Maintain consistency
• Manage their own work and family responsibilities

Even motivated families can become overwhelmed.

A residential program creates an environment where nutrition, routines, movement, cognitive engagement, sleep support, education, and daily monitoring can be integrated more consistently.

The value is not only the testing.

The value is using the findings to shape daily life.

How MCRC Uses Testing Within Its Residential Program

Michigan Cognitive Recovery Center is located at Lakeshore Woods Senior Living in Fort Gratiot, Michigan.

It is one of only two U.S. senior living centers offering the ReCODE+ For Facilities Program™ in partnership with Apollo Health.

The 12-month residential program is designed for adults with:

• Subjective cognitive impairment
• Mild cognitive impairment
• Early-stage Alzheimer’s disease

Every participant begins with a comprehensive assessment that includes cognitive testing and laboratory work covering more than 36 biomarkers connected with cognitive health.

The findings help guide a personalized ReCODE Report™ and structured plan.

The program may integrate:

• Nutrition
• Exercise
• Sleep support
• Stress management
• Brain stimulation
• Supplementation
• Detoxification support when appropriate
• Education
• Health coaching
• Clinical coordination
• Daily residential structure
• Ongoing monitoring

MCRC is not presented as a standalone laboratory or diagnostic clinic.

The testing is part of the enrollment and personalization process for the complete residential program.

Clinical assessment is required to determine whether a prospective participant is an appropriate candidate.

Questions Families Should Ask About Cognitive Biomarker Testing

Before enrolling in any cognitive recovery or precision-medicine program, families should ask:

• What tests are included?
• Why is each test being ordered?
• Are the tests diagnostic or used to investigate possible contributors?
• Who interprets the results?
• What qualifications does that person have?
• How are cognitive testing and laboratory findings considered together?
• How will abnormal findings change the daily plan?
• Will the participant’s physician be involved?
• Which results may require specialist referral?
• How often will testing be repeated?
• How are medication and supplement interactions monitored?
• How are progress and safety evaluated?
• Are there additional laboratory costs?
• What happens when a result is unclear?
• How will the family receive updates?

A responsible program should be able to explain the purpose of testing without promising a cure or guaranteed outcome.

What Alzheimer’s Biomarker Testing Cannot Tell Families

Testing has limitations.

It cannot:

• Predict an exact cognitive outcome
• Guarantee that decline will stop
• Guarantee that cognition will improve
• Replace a complete medical evaluation
• Explain every symptom
• Show that one abnormal value caused the decline
• Determine the correct treatment without clinical interpretation
• Replace cognitive testing
• Replace assessment of daily function
• Make every participant appropriate for the same program

Even Alzheimer’s-specific biomarkers must be interpreted within an appropriate diagnostic process.

Broader health biomarkers can identify areas that deserve attention, but they do not automatically prove the cause of a person’s memory problems.

Testing should create better questions and clearer priorities.

It should not create false certainty.

When Should a Family Consider a Comprehensive Assessment?

A comprehensive evaluation may be worth discussing when a person or family notices persistent changes such as:

• Repeating questions
• Forgetting recent conversations
• Increased word-finding difficulty
• Missed appointments
• Difficulty managing bills
• Problems following familiar recipes
• Reduced organization
• Getting lost in familiar places
• Personality or judgment changes
• Increasing reliance on reminders
• A consistent feeling of mental fog
• Cognitive changes that seem different from normal aging

Sudden confusion, weakness, speech difficulty, severe headache, loss of consciousness, or other acute neurological symptoms require urgent medical attention.

Gradual cognitive changes should still be discussed with a qualified healthcare professional.

Early evaluation can help families establish a baseline, identify potentially relevant contributors, and understand whether monitoring, medical treatment, specialist referral, or a structured program may be appropriate.

Take the Next Step

Comprehensive laboratory testing can help reveal that cognitive decline is rarely a one-number problem.

Inflammation, metabolic health, nutrient status, thyroid function, hormones, vascular risk, sleep, medications, genetics, and other factors may overlap differently in each person.

The purpose of testing is not to produce the longest possible list of abnormalities.

It is to identify the most meaningful priorities and translate them into a safe, practical, and personalized plan.

At Michigan Cognitive Recovery Center, cognitive testing and laboratory work covering more than 36 biomarkers are used as part of the assessment process for the 12-month ReCODE+ For Facilities Program™.

Families can contact MCRC to learn what the assessment involves and whether their loved one may be an appropriate candidate.

Michigan Cognitive Recovery Center
At Lakeshore Woods Senior Living
4851 Lakeshore Rd
Fort Gratiot, MI 48059
Phone: (810) 385-3185

Learn more about the Michigan ReCODE+ residential program.

Frequently Asked Questions

Medical Disclaimer

This article is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Laboratory values, cognitive symptoms, medication use, medical history, and individual risks should be evaluated by qualified healthcare professionals.

Blood-based biomarkers should not be used as standalone proof of Alzheimer’s disease without an appropriate clinical diagnostic process. Broader metabolic, nutritional, inflammatory, hormonal, vascular, immune, or environmental biomarkers do not independently diagnose Alzheimer’s disease.

The ReCODE Protocol™ and ReCODE+ For Facilities Program™ are not cures for Alzheimer’s disease. Individual results vary, and no cognitive, functional, laboratory, or medical outcome can be guaranteed.

A clinical assessment by qualified MCRC staff is required before enrollment. MCRC’s laboratory and cognitive assessment is part of its 12-month residential program and is not presented as a standalone outpatient diagnostic service. The program is not a substitute for care from a licensed physician.

About the Author

This article was written by the Lakeshore Woods Team. Lakeshore Woods Senior Living in Fort Gratiot Township, Michigan, is home to Michigan Cognitive Recovery Center, one of only two U.S. senior living centers offering the ReCODE+ For Facilities Program™ in partnership with Apollo Health.